NCT03782662View on ClinicalTrials.gov

A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

March 17, 2019

Study Completion Date

March 17, 2019

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

Itraconazole

Itraconazole capsules

DRUG

Verapamil

Verapamil tablets

DRUG

Rifampicin

Rifampicin capsules

DRUG

Midazolam

Midazolam oromucosal solution

DRUG

Placebo for RV521

Placebo for RV521 capsules

DRUG

RV521

RV521 capsules

Trial Locations (1)

SE1 1YR

Richmond Pharmacology Ltd, London

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03782662 - A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants | Biotech Hunter | Biotech Hunter